FLANAGAN MARTIN L
Known title: President & CEOCIK: 0001010267
Associated companies
Transaction History
| IVZ | ▼ Sell | Open Market | 232,413 | $4.1M | 3/1/2023 | View on chart |
| IVZ | ▲ Buy | Grant | 161,879 | $0 | 2/28/2023 | View on chart |
| IVZ | ▲ Buy | Grant | 186,089 | $0 | 2/28/2023 | View on chart |
| IVZ | ▼ Sell | Tax Withholding | 150,796 | $2.7M | 2/28/2023 | View on chart |
| IVZ | ▼ Sell | Open Market | 189,708 | $3.7M | 3/1/2022 | View on chart |
| IVZ | ▲ Buy | Grant | 135,163 | $0 | 2/28/2022 | View on chart |
| IVZ | ▲ Buy | Grant | 211,864 | $0 | 2/28/2022 | View on chart |
| IVZ | ▼ Sell | Tax Withholding | 123,087 | $2.6M | 2/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Invesco to Report Q3 2026 Results; Dividends Declared
Invesco has announced it will release its third-quarter 2026 financial results soon. The company also declared dividends for its closed-end funds, a move that may appeal to income-focused investors given the stock's 5.79% dividend yield. Recent news coverage has focused on the firm's various ETFs and mutual funds, highlighting its broad product lineup.
Invesco to Report Q3 2026 Results; Dividends Declared. Invesco has announced it will release its third-quarter 2026 financial results soon. The company also declared dividends for its closed-end funds, a move that may appeal to income-focused investors given the stock's 5.79% dividend yield. Recent news coverage has focused on the firm's various ETFs and mutual funds, highlighting its broad product lineup.